TBG Diagnostics Ltd (TDL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:TBG Diagnostics Ltd (TDL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7484
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent reference labs, blood centers and bone marrow registry labs worldwide. It has research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. The company has collaboration and product licensing agreements with various pharmaceutical companies and others to expand market presence and product portfolio. TBG Diagnostics is headquartered in Greenslopes, Queensland, Australia.

TBG Diagnostics Ltd (TDL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
TBG Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TBG Diagnostics Ltd, Medical Equipment, Deal Details 10
Partnerships 10
TBG Diagnostics and Medigen Enter into Licensing Agreement with National Taiwan University Hospital 10
TBG Biotechnology Forms Joint Venture with Xiamen Haicang Biotechnology Development 11
Omixon Enters into Distribution Agreement with TBG Diagnostics 12
Acquisition 13
TBG Diagnostics to Acquire 51% Stake in RBC Biosciences for USD4 Million 13
Progen Pharma Acquires TBG from Medigen Biotech 14
TBG Diagnostics Ltd – Key Competitors 15
TBG Diagnostics Ltd – Key Employees 16
TBG Diagnostics Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Apr 26, 2018: TBG Diagnostics: Director Appointment /Resignation
Legal and Regulatory 19
Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
TBG Diagnostics Ltd, Medical Equipment, Key Facts, 2017 2
TBG Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Deals By Market, 2012 to YTD 2018 8
TBG Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TBG Diagnostics and Medigen Enter into Licensing Agreement with National Taiwan University Hospital 10
TBG Biotechnology Forms Joint Venture with Xiamen Haicang Biotechnology Development 11
Omixon Enters into Distribution Agreement with TBG Diagnostics 12
TBG Diagnostics to Acquire 51% Stake in RBC Biosciences for USD4 Million 13
Progen Pharma Acquires TBG from Medigen Biotech 14
TBG Diagnostics Ltd, Key Competitors 15
TBG Diagnostics Ltd, Key Employees 16
TBG Diagnostics Ltd, Other Locations 17
TBG Diagnostics Ltd, Subsidiaries 17

List of Figures
TBG Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[TBG Diagnostics Ltd (TDL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Koch Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Koch Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Koch Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Enviva Partners LP (EVA):企業の財務・戦略的SWOT分析
    Enviva Partners LP (EVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • UGI Corporation (UGI)-石油・ガス分野:企業M&A・提携分析
    Summary UGI Corporation (UGI) is a holding company providing energy products and services. Through a network of subsidiaries, the company stores, transports, distributes and markets energy products and related services. It serves as a domestic and international retail distributor of propane and buta …
  • Nabriva Therapeutics plc (NBRV):企業の財務・戦略的SWOT分析
    Summary Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company offers product candidate such as Xenleta (lefamulin), CONTEPO (fosfomycin), being developed in both intravenous and oral formulations for th …
  • Yandex NV (YNDX):企業の財務・戦略的SWOT分析
    Yandex NV (YNDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MI Bioresearch Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc, is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous …
  • Teva Pharmaceutical Industries Ltd (TEVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • Acorda Therapeutics Inc (ACOR):企業の財務・戦略的SWOT分析
    Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sprint Corporation:企業の戦略・SWOT・財務情報
    Sprint Corporation - Strategy, SWOT and Corporate Finance Report Summary Sprint Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Chesnara plc:企業の戦略・SWOT・財務情報
    Chesnara plc - Strategy, SWOT and Corporate Finance Report Summary Chesnara plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Crescent Point Energy Corp (CPG):石油・ガス:M&Aディール及び事業提携情報
    Summary Crescent Point Energy Corp (Crescent Point) is an oil and gas company. It acquires, explores, develops and produces light and medium crude oil, heavy crude oil, tight oil, natural gas liquids, shale gas and conventional natural gas. The company holds interest in light and medium oil and natu …
  • The Bank of East Asia, Limited:企業のM&A・事業提携・投資動向
    The Bank of East Asia, Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Bank of East Asia, Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Invenra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Invenra Inc (Invenra) is a healthcare services provider that offers therapeutic solutions. The company discovers therapeutic human antibodies and their derivatives. It uses its proprietary technology to combine the ribosome display, cell free expression of antibodies with miniaturization, mi …
  • Vivimed Labs Ltd (VIVIMEDLAB)-製薬・医療分野:企業M&A・提携分析
    Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufacture …
  • Vertu Motors Plc:企業のM&A・事業提携・投資動向
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • RPP Infra Projects Ltd (RPPINFRA):企業の財務・戦略的SWOT分析
    RPP Infra Projects Ltd (RPPINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Meta Biomed Co Ltd (059210):企業の製品パイプライン分析2018
    Summary Meta Biomed Co Ltd (Meta Biomed) is a medical device company that develops and manufactures dental materials and equipments. The company provides suture, dental, bone and medical products. It offers various medical products such as endodontic materials, bone restorative materials, implant ma …
  • Neurovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurovance Inc (Neurovance) is a clinical stage neuroscience focused company that develops centanafadine (CTN) SR for adult and pediatric Attention Deficit Hyperactivity Disorder (ADHD). CTN, formerly EB-1020, is a novel triple reuptake inhibitor that acts as a functional hybrid with activit …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • HCA Healthcare Inc (HCA):製薬・医療:M&Aディール及び事業提携情報
    Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆